Cannabis gummy could help shed pounds, early trial hopes

NCT ID NCT06137365

Recruiting now Disease control Sponsor: Joshua A. Lile, Ph.D. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This Phase 2 study will test whether a once-daily cannabis gummy can help people with obesity lose weight. Forty adults aged 18–65 with a BMI of 30 or higher will receive either the cannabis gummy or a placebo for a set period. The main goal is to measure changes in body weight.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabis gummy (cannabis flower extract)
What this could lead to: If it works, this could point toward a new weight-loss option for people with obesity.
What could go wrong: This is a small, early-stage trial with only 40 participants. It may not show significant weight loss, and long-term safety is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY

Contacts and locations

Locations

University of Kentucky
RECRUITING

Lexington, Kentucky, 40517, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.